Header Logo

Connection

SUSAN BLANEY to Neuroectodermal Tumors, Primitive, Peripheral

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Neuroectodermal Tumors, Primitive, Peripheral.
SUSAN BLANEY
Connection Strength
0.037
Neuroectodermal Tumors, Primitive, Peripheral
  1. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Clin Cancer Res. 1998 Feb; 4(2):357-60.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.